AI startup Lunit has received the approval of Singapore's Health Sciences Authority to commercialise its AI diagnostic tools for analysing chest x-ray and breast mammography.
WHAT THEY DO
Both AI products are under the Lunit INSIGHT product line. According to a press statement, the Lunit INSIGHT CXR and INSIGHT MMG provide lesion detection with around 96-99% accuracy and visualise the location of...
Multinational medical imaging device maker Fujifilm Corporation has received the approval of Japan's Pharmaceuticals and Medical Devices Agency for its latest AI-powered chest x-ray software.
WHAT IT DOES
The Fujifilm CXR-AID detects major abnormal findings from chest radiographs, such as chest nodule, consolidation and pneumothorax.
Based on a press statement, the diagnostic system runs on...
AI startup Lunit from South Korea has bagged $26 million in a Series C Tranche B funding round. The investment came from Guardant Health, a Nasdaq-listed precision oncology firm.
WHAT IT DOES
Founded in 2013, Lunit develops AI software in the oncology space. Its solutions are designed to discover cancer and predict cancer treatment outcomes.
One of its tech solutions, tissue analysis platform...
